Pertussis vaccine

DB15274ApprovedInvestigationalVaccines

Pertussis vaccine is under investigation in clinical trial NCT01698346 (Pertussis (Tdap) Vaccination in Pregnancy).

First approval
Canada, 2000 · European Union, 2021
Also known as
Bordetella pertussis
Brand names
  • Infanrix Hexa

Resolves to

Compound
UNII2QNL82089R
Clinical / RWD
RxNorm1608803

What you can answer from here — as of April 02, 2025

289Drug interactionsStructured to mechanism, not free text
Sign in
121Clinical trialsPhase, status and sponsor resolved per trial
Sign in
33Marketed productsAcross 7 countries and 8 labellers
Sign in

Which companies are running trials of Pertussis vaccine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In